Ispire Technology Inc. Reports 22.8% Revenue Decline and $3.3 Million Net Loss for Quarter Ending September 30, 2025

Ispire Technology Inc. reported a significant decline in financial performance for the three months ending September 30, 2025, with revenues totaling $30.4 million, a decrease of 22.8% from $39.3 million in the same period last year. The company's gross profit also fell to $5.1 million, down 32.9% from $7.7 million, resulting in a gross margin reduction from 19.5% to 17.0%. The net loss for the quarter was $3.3 million, or $(0.06) per share, compared to a net loss of $5.6 million, or $(0.10) per share, in the prior year. This reduction in losses indicates some operational improvements despite the overall revenue decline.

The decrease in revenue was attributed to several factors, including a $4.2 million drop in sales in the United States, which fell from $9.7 million to $5.5 million. Additionally, sales in other regions, particularly South Africa, also saw declines. The company noted that the decrease in revenue was consistent with a reduction in product sales across various markets, including Europe and Asia Pacific. Operating expenses decreased significantly by 39.4% to $7.8 million, primarily due to reduced sales and marketing expenses and lower credit loss expenses, which fell by 43.1% as a result of improved collection efforts.

Strategically, Ispire has been expanding its operational footprint, having established several subsidiaries in key markets, including Malaysia and the UAE, to enhance its manufacturing and sales capabilities. The company is also focusing on its joint venture with IKE Tech LLC, which aims to develop age-verification solutions for vapor devices in the U.S. market. As of September 30, 2025, Ispire's total assets were reported at $96.4 million, with current liabilities decreasing to $65.8 million from $72.5 million, indicating improved working capital management.

In terms of operational metrics, Ispire's accounts receivable stood at $44.5 million, reflecting a decrease from $47.0 million, while the allowance for credit losses was $17.3 million. The company has also been actively managing its inventory, with reserves increasing to $1.4 million. The total employee headcount has been adjusted in line with operational needs, contributing to the reduction in general and administrative expenses.

Looking ahead, Ispire remains cautious about market conditions and regulatory challenges, particularly in the vaping industry. The company is focused on enhancing its product offerings and expanding its market presence, especially in regions where cannabis vaping products are becoming legalized. Ispire's management believes that the current cash reserves and operational strategies will be sufficient to meet working capital needs over the next 12 months, although they acknowledge the potential need for additional financing to support growth initiatives.